Condition
Secondary Insomnia
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (2)
Trial Status
Completed3
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT01804036Phase 2Completed
Two Contrasting Interventions for Sleep Management
NCT00105872Not ApplicableCompleted
Behavioral Insomnia Therapy in Primary Care
NCT00235365Not ApplicableWithdrawnPrimary
Metacognitive Therapy for Comorbid Insomnia
NCT00784875Phase 2Completed
An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia
Showing all 4 trials